BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3328905)

  • 1. [Auriculo-electropuncture in rheumatoid arthritis (a double-blind study)].
    Ruchkin IN; Burdeĭnyĭ AP
    Ter Arkh; 1987; 59(12):26-30. PubMed ID: 3328905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuro-reflexotherapy for the management of myofascial temporomandibular joint pain: a double-blind, placebo-controlled, randomized clinical trial.
    Berguer A; Kovacs F; Abraira V; Mufraggi N; Royuela A; Muriel A; Gestoso M; Falahat F; Martín-Granizo R; Zamora J
    J Oral Maxillofac Surg; 2008 Aug; 66(8):1664-77. PubMed ID: 18634956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunoglobulin therapy of rheumatoid arthritis].
    Seisenbaev ASh; Balabanova RM; Baryshnikov AIu; Denisov LN; Tupitsin NN
    Revmatologiia (Mosk); 1990; (1):8-12. PubMed ID: 2377868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose prednisone therapy in rheumatoid arthritis: a double blind study.
    Harris ED; Emkey RD; Nichols JE; Newberg A
    J Rheumatol; 1983 Oct; 10(5):713-21. PubMed ID: 6358491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M
    Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two configurations of static magnetic fields for treating rheumatoid arthritis of the knee: a double-blind clinical trial.
    Segal NA; Toda Y; Huston J; Saeki Y; Shimizu M; Fuchs H; Shimaoka Y; Holcomb R; McLean MJ
    Arch Phys Med Rehabil; 2001 Oct; 82(10):1453-60. PubMed ID: 11588753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filtration leukocytapheresis therapy in rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial.
    Hidaka T; Suzuki K; Matsuki Y; Takamizawa-Matsumoto M; Kataharada K; Ishizuka T; Kawakami M; Nakamura H
    Arthritis Rheum; 1999 Mar; 42(3):431-7. PubMed ID: 10088764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptides.
    Moreland LW; Morgan EE; Adamson TC; Fronek Z; Calabrese LH; Cash JM; Markenson JA; Matsumoto AK; Bathon J; Matteson EL; Uramoto KM; Weyand CM; Koopman WJ; Heck LW; Strand V; Diveley JP; Carlo DJ; Nardo CJ; Richieri SP; Brostoff SW
    Arthritis Rheum; 1998 Nov; 41(11):1919-29. PubMed ID: 9811045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter double-blind controlled study of lobenzarit, a novel immunomodulator, in rheumatoid arthritis.
    Shiokawa Y; Horiuchi Y; Mizushima Y; Kageyama T; Shichikawa K; Ofuji T; Honma M; Yoshizawa H; Abe C; Ogawa N
    J Rheumatol; 1984 Oct; 11(5):615-23. PubMed ID: 6392550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical effect of glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapies.
    van Everdingen AA; Siewertsz van Reesema DR; Jacobs JW; Bijlsma JW
    Arthritis Rheum; 2004 Apr; 51(2):233-8. PubMed ID: 15077265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, multicenter, controlled clinical trial of chicken type II collagen in patients with rheumatoid arthritis.
    Zhang LL; Wei W; Xiao F; Xu JH; Bao CD; Ni LQ; Li XF
    Arthritis Rheum; 2008 Jul; 59(7):905-10. PubMed ID: 18576295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind randomized trial of diclofenac sodium versus placebo in patients with rheumatoid arthritis.
    Weisman MH
    Clin Ther; 1986; 8(4):427-38. PubMed ID: 3524843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, multicenter, controlled clinical trial of cyclosporine plus chloroquine vs. cyclosporine plus placebo in early-onset rheumatoid arthritis.
    Miranda JM; Alvarez-Nemegyei J; Saavedra MA; Terán L; Galván-Villegas F; García-Figueroa J; Jara LJ; Barile L;
    Arch Med Res; 2004; 35(1):36-42. PubMed ID: 15036798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant auricular electroacupuncture and autogenic training in rheumatoid arthritis: a randomized controlled trial. Auricular acupuncture and autogenic training in rheumatoid arthritis.
    Bernateck M; Becker M; Schwake C; Hoy L; Passie T; Parlesak A; Fischer MJ; Fink M; Karst M
    Forsch Komplementmed; 2008 Aug; 15(4):187-93. PubMed ID: 18787327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of psoriatic arthritis with gold salts (chrysotherapy)].
    Burdeĭnyĭ AP; Sigidin IaA; Novoselova TM
    Ter Arkh; 1986; 58(7):38-43. PubMed ID: 3532401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sick building syndrome (SBS) and exposure to water-damaged buildings: time series study, clinical trial and mechanisms.
    Shoemaker RC; House DE
    Neurotoxicol Teratol; 2006; 28(5):573-88. PubMed ID: 17010568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
    Cohen SB; Emery P; Greenwald MW; Dougados M; Furie RA; Genovese MC; Keystone EC; Loveless JE; Burmester GR; Cravets MW; Hessey EW; Shaw T; Totoritis MC;
    Arthritis Rheum; 2006 Sep; 54(9):2793-806. PubMed ID: 16947627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis.
    Rau R; Sander O; van Riel P; van de Putte L; Hasler F; Zaug M; Kneer J; van der Auwera P; Stevens RM;
    J Rheumatol; 2003 Apr; 30(4):680-90. PubMed ID: 12672184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial.
    Lee EY; Lee EB; Park BJ; Lee CK; Yoo B; Lim MK; Shim SC; Sheen DH; Seo YI; Kim HA; Baek HJ; Song YW
    Clin Ther; 2006 Dec; 28(12):2052-60. PubMed ID: 17296461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.
    Lehman AJ; Esdaile JM; Klinkhoff AV; Grant E; Fitzgerald A; Canvin J;
    Arthritis Rheum; 2005 May; 52(5):1360-70. PubMed ID: 15880810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.